ecancermedicalscience

Review

Conducting Phase IV clinical studies: a moral imperative?

26 Oct 2012
TP Hill

The answer to this question lies in knowing the moral standing of Phase IV studies and whether we ought to conduct them. And to know this, in part, we need to compare them to studies in Phases I, II, and III and then determine where Phase IV studies stand in relation to Phase I–III studies scientifically and commercially.

Related Articles

Eniola R Kadir, Kikelomo T Adesina, Olatunde Oyebanjo K Ibrahim, Beatrice O Owolabi, Olaniyi O Fatai, Tomilola M Olaseinde, Azeezat D Yakub, Hafsat A Ameen, Suleiman O Agodirin, Adegboyega A Fawole
Rajsinh Bhosale, Lamiya Pirzada, Safiyyah Khan, Aqsa Zainab, Shravya Subashini Sivaramakrishnan, Areeba Mariam Mehmood, Pawan Sapkota Upadhya
Paulina B Crespo-Morfin, Rodrigo Figueroa-Mendez, Eleazar Ignacio-Álvarez, Miguel A Ávila-Rodríguez, Alfredo A Reza-Albarrán
Roberta Monteiro Batista Sarmento, José Roberto Lapa e Silva, Gustavo Arantes Rosa Maciel, Claudia Ferrer, José Bines